Senti Biosciences Holdings reported revenue of $0.02M and net income of -$12.75M for the quarter ended Jun 2026. This income statement covers 21 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 2.90M | 2.95M | 0.65M | 2.95M | 1.34M | 4.36M | 2.61M | 4.41M | 4.45M | 4.45M | 4.57M | 4.57M | 4.57M | 4.59M | 4.83M | 10.01M | 26.16M | 26.29M | 22.48M | 31.14M | |
| Revenue & cost | |||||||||||||||||||||
| Revenue | 0.79M | 1.10M | 0.79M | 1.10M | 1.36M | 1.77M | 0.06M | 1.29M | 0.94M | 0.34M | 0.02M | ||||||||||
| Operating items | |||||||||||||||||||||
| Research & DevelopmentR&D | 5.24M | 5.41M | 6.41M | 7.60M | 9.25M | 6.52M | 7.04M | 7.06M | 6.88M | 9.09M | 9.12M | 8.78M | 9.15M | 8.65M | 7.77M | 9.28M | 10.03M | 10.52M | 7.76M | 7.77M | |
| Wages, Salaries and OtherWages | 3.70M | ||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 4.55M | 7.12M | 5.27M | 5.26M | 13.88M | 9.99M | 9.82M | 9.19M | 9.25M | 9.43M | 9.30M | 7.52M | 4.21M | 6.56M | 8.08M | 7.12M | 6.77M | 6.43M | 5.85M | 6.74M | |
| Other Operating ExpensesOther Opex | 25.69M | 0.27M | 0.31M | 5.05M | |||||||||||||||||
| Operating ExpensesOpex | 9.79M | 12.53M | 11.68M | 12.86M | 23.13M | 16.51M | 16.85M | 16.25M | 16.12M | 44.21M | 18.70M | 16.30M | 13.36M | 15.21M | 16.17M | 16.40M | 16.80M | 16.95M | 18.66M | 14.51M | |
| Operating IncomeOp. Inc | -9.00M | -11.42M | -3.87M | -11.76M | -21.77M | -14.75M | -16.79M | -14.96M | -15.19M | -43.88M | -18.70M | -16.30M | -13.36M | -15.21M | -16.17M | -16.40M | -16.80M | -16.95M | -18.64M | -14.49M | |
| EBIT | -9.00M | -11.42M | -3.87M | -11.76M | -21.77M | -14.75M | -16.79M | -14.96M | -15.19M | -43.88M | -18.70M | -16.30M | -13.36M | -15.21M | -16.17M | -16.40M | -16.80M | -16.95M | -18.64M | -14.49M | |
| Non-operating items | |||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | 0.01M | 0.01M | 0.00M | 0.03M | 0.54M | 1.13M | 1.06M | 0.79M | 0.58M | 0.43M | 0.33M | 0.24M | 0.15M | 0.23M | 0.39M | 0.27M | 0.17M | 0.10M | 0.06M | |
| Other Non Operating IncomeOther Non Op Inc. | -0.10M | 0.02M | -0.01M | -0.05M | 1.29M | 0.00M | -0.01M | -0.00M | -0.01M | -0.01M | 0.01M | -0.01M | 0.21M | 0.20M | 0.21M | 0.22M | 0.19M | 0.42M | |||
| Non Operating IncomeNon Op. Inc. | -3.01M | 0.02M | -0.02M | -0.05M | 10.22M | 0.45M | 1.81M | 1.11M | 0.94M | 7.26M | 0.01M | 4.19M | 2.15M | -13.65M | 15.56M | 2.29M | 2.06M | -1.18M | 4.17M | 1.74M | |
| Net income details | |||||||||||||||||||||
| EBT | -8.99M | -11.42M | -3.86M | -11.75M | -21.74M | -14.21M | -15.67M | -13.90M | -14.39M | -43.29M | -18.27M | -15.97M | -13.12M | -15.06M | -15.94M | -16.00M | -16.53M | -16.78M | -18.54M | -14.43M | |
| Profit After TaxPAT | -12.01M | -11.41M | -3.86M | -11.81M | -11.55M | -16.64M | -58.21M | -18.72M | -18.70M | -36.62M | -83.41M | -12.11M | -11.20M | -28.87M | -0.60M | -14.11M | -14.73M | -18.13M | -14.44M | -12.75M | |
| Income from Non-Controlling InterestsInc. Minority | 0.90M | 1.42M | 1.46M | 1.59M | 1.66M | 1.74M | 1.89M | 1.79M | 1.42M | ||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -8.99M | -11.42M | -3.86M | -11.75M | -21.74M | -14.21M | -15.67M | -13.90M | -14.39M | -43.29M | -18.27M | -15.97M | -13.12M | -15.06M | -15.94M | -16.00M | -16.53M | -16.78M | -18.54M | -14.43M | |
| Income from Discontinued OperationsIncome (Discontinued) | -2.34M | -8.54M | -4.87M | -4.45M | 21.69M | -0.03M | |||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -8.99M | -11.42M | -3.86M | -11.75M | -21.74M | -16.54M | -24.21M | -18.77M | -18.84M | -21.60M | -18.30M | -15.97M | -13.12M | -15.06M | -15.94M | -16.00M | -16.53M | -16.78M | -18.54M | -14.43M | |
| Income towards Parent CompanyParent Net Inc | -8.99M | -11.42M | -3.86M | -11.75M | -21.74M | -16.54M | -24.21M | -18.77M | -18.84M | -21.60M | -18.30M | -15.97M | -13.12M | -15.06M | -15.94M | -16.00M | -16.53M | -16.78M | -18.54M | -14.43M | |
| Net Income towards Common StockholdersNet Income | -8.99M | -11.42M | -3.86M | -11.75M | -21.74M | -16.54M | -24.21M | -18.77M | -18.84M | -21.60M | -18.30M | -12.11M | -11.20M | -28.87M | -15.94M | -14.11M | -14.73M | -18.13M | -18.54M | -14.43M | |
| Additional items | |||||||||||||||||||||
| EPS (Basic) | -3.10 | -3.88 | -13.24 | -3.99 | -16.17 | -3.81 | -9.27 | -4.26 | -4.26 | -4.86 | -4.12 | -2.65 | -2.45 | -6.31 | -3.47 | -1.41 | -0.56 | -0.69 | -0.82 | -0.46 | |
| EPS (Diluted) | -30.92 | -39.02 | -13.24 | -37.06 | -16.17 | -3.81 | -9.27 | -4.26 | -4.26 | -4.86 | -4.12 | -2.65 | -2.45 | -6.31 | -3.47 | -1.41 | -0.56 | -0.69 | -0.82 | -0.46 | |
| Shares Outstanding | 2.90M | 2.95M | 0.29M | 2.95M | 1.34M | 4.34M | 2.61M | 4.41M | 4.43M | 4.45M | 4.44M | 4.57M | 4.57M | 4.58M | 4.60M | 10.01M | 26.08M | 26.23M | 22.48M | 31.14M | |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.29M | 0.29M | 0.29M | 0.32M | 1.34M | 4.34M | 2.61M | 4.41M | 4.43M | 4.45M | 4.44M | 4.57M | 4.57M | 4.58M | 4.60M | 10.01M | 26.08M | 26.23M | 22.48M | 31.14M | |
| EBITDA | -9.00M | -11.42M | -3.87M | -11.76M | -21.77M | -14.75M | -16.79M | -14.96M | -15.19M | -43.88M | -18.70M | -16.30M | -13.36M | -15.21M | -16.17M | -16.40M | -16.80M | -16.95M | -18.64M | -14.49M |